Trials / Completed
CompletedNCT01882062
Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this project is to study the efficacy of an anaplerotic treatment on brain energy profile evolution at an early stage of the Huntington disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triheptanoin 1g/kg/day |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2013-06-20
- Last updated
- 2026-03-25
- Results posted
- 2016-03-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01882062. Inclusion in this directory is not an endorsement.